Madrigal Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · West Conshohocken, PA
MDGL chart
What traders are saying about $MDGL
Latest postsMadrigal Pharmaceuticals, Inc. news
- Kaplan Fox is Investigating Madrigal Pharmaceuticals, Inc. (NASDA
The National Law Review ·
- Madrigal Pharmaceuticals stock faces scrutiny over data allegations
ad-hoc-news.de ·
- Is Madrigal Pharmaceuticals (MDGL) Cheap Following Rezdiffra Data And A Swing To Net Income?
Simply Wall St ·
- Madrigal Pharmaceuticals, Inc. (MDGL) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- 4 Commercial-Stage Biotechs Poised for Sustained Revenue Growth
Yahoo Finance ·
- West Conshohocken’s Madrigal Pharmaceuticals Turns Homegrown Liver Drug Into a $1 Billion Seller
MONTCO.Today ·
- MDGL Investors Have Opportunity to Join Madrigal Pharmaceuticals, Inc. Fraud Investigation with SBS Law
Business Wire ·
- What Does Madrigal Pharmaceuticals (MDGL) Whistleblower Probe Mean For Investors?
Simply Wall St ·
- Form 144 MADRIGAL PHARMACEUTICALS For: 7 November By Investing.com
Investing.com India ·
- Form 4 Madrigal Pharmaceuticals Inc: Shannon T. Kelley (General Counsel) For: 6 November By Investing.com
Investing.com India ·
- Madrigal Pharmaceuticals faces whistleblower cl...
Pluang ·
- Notice of Investigation of MDGL: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP
PR Newswire ·
Madrigal Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $958.4M | $180.1M | $0 | $0 |
| Net income | -$288.3M | -$465.9M | -$373.6M | -$295.3M |
| Diluted EPS | $-10.15 | $-17.31 | $-17.33 | $-17.23 |
| Total assets (year end) | $1.26B | $1.04B | $640.5M | $362.6M |
| Cash and equivalents (year end) | $198.7M | $100.0M | $99.9M | $331.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Madrigal Pharmaceuticals, Inc.
- Ticker
- MDGL (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- West Conshohocken, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1157601
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
Frequently asked questions
What exchange is Madrigal Pharmaceuticals, Inc. listed on?
Madrigal Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol MDGL.
What industry is Madrigal Pharmaceuticals, Inc. in?
Madrigal Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Madrigal Pharmaceuticals, Inc. headquartered?
Madrigal Pharmaceuticals, Inc.'s business address on file with the SEC is in West Conshohocken, PA.
When does Madrigal Pharmaceuticals, Inc.'s fiscal year end?
Madrigal Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Madrigal Pharmaceuticals, Inc. report?
Madrigal Pharmaceuticals, Inc. reported $958.4M in revenue for calendar year 2025, according to its SEC filings.